Tamizaje nacional unificado de hipotiroidismo congénito en el Perú: Un programa inexistente

Translated title of the contribution: National congenital hypothyroidism screening in Peru: A broken program

Lina Huerta-Sáenz, Carlos Del Águila, Oscar Espinoza, Juan Falen-Boggio, Naim Mitre

Research output: Contribution to journalArticle

1 Scopus citations


Congenital hypothyroidism (CH) is the most important cause of preventable mental retardation. The prevalence of CH varies by geographic region, race and ethnicity. In the countries of the Northern hemisphere, the prevalence has been reported as 1:4,000 live newborns. The prevalence is remarkably different among the countries of Latin America not only because of their different races and ethnicities but also because of the heterogeneous social-economic development. The prevalence of CH in 1984 in Peru was reported as 1:1250. In 2007, the reported incidence by the Instituto Nacional Materno Perinatal was 1:1638. A recent retrospective study performed by the Instituto Nacional de Salud del Niño in Lima, Peru described the average age of diagnosis of CH as 5,9 months +/- 5,28. This late age of CH diagnosis certainly suggests the poor efficiency of the current neonatal CH screening programs in Peru. Every Peruvian infant deserves a timely newborn screening and treatment for CH. The Peruvian government is responsible for ensuring this mandatory goal is achieved promptly.

Original languageSpanish
Pages (from-to)579-585
Number of pages7
JournalRevista Peruana de Medicina Experimental y Salud Publica
Issue number3
Publication statusPublished - Jul 1 2015


All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this